Cartilage degeneration is among the fundamental reasons behind disability and pain across
the globe. Numerous approaches have been employed to treat cartilage diseases …

Drug evaluation has always been an important area of research in the pharmaceutical
industry. However, animal welfare protection and other shortcomings of traditional drug …

Microfluidic is a technology that allows the precise control of fluid in a micro-channel. With its
advantages of high throughput and low cost, microfluidic technology has achieved good …

Osteoarthritis (OA) remains a prevalent disease affecting more than 20% of the global
population, resulting in morbidity and lower quality of life for patients. The study of OA …

Abstract Degenerative musculoskeletal diseases (Osteoporosis, Osteoarthritis,
Degenerative Spinal Disease and Sarcopenia) are pathological conditions that affect the …

Osteoarthritis (OA), a prevalent degenerative condition, occurs due to the deterioration of
joint tissues and cells. Consequently, safeguarding chondrocytes against damage caused …

Rheumatoid arthritis (RA) affects millions of people worldwide, but there are limited drugs
available to treat it, so acquiring a more comprehensive comprehension of the underlying …

Rheumatoid arthritis (RA) and osteoarthritis (OA) are prevalent inflammatory joint diseases
characterized by synovitis, cartilage, and bone destruction. Fibroblast-like synoviocytes …

Rheumatoid arthritis (RA) is one of the leading causes of disability due to the autoimmune
destruction of synovial joints. Great efforts have been put into developing multifunctional …

Objective This study aims to tackle the existing challenges associated with the prediction
and optimization of pharmaceutical interventions for osteoarthritis (OA). The primary …